Search - tctmd.com

Displaying 181 - 192 of 192

Sort: Relevancy | Date

Major CVD Outcomes Trial Testing PCSK9 Inhibitor Evolocumab Meets Primary Endpoint

News Daily News

Major CVD Outcomes Trial Testing PCSK9 Inhibitor Evolocumab Meets Primary Endpoint

Michael O'Riordan

February 03, 2017

How Low Can Cholesterol Go? Safety Not in Limbo for Patients With Very Low LDL on Alirocumab, Study Shows

News Daily News

How Low Can Cholesterol Go? Safety Not in Limbo for Patients With Very Low LDL on Alirocumab, Study Shows

Yael L. Maxwell

January 31, 2017

News Daily News

Meta-analysis Adds Support to More Intensive Lowering of BP in Older Patients With Hypertension

January 30, 2017

News Daily News

Meta-analysis Calls Into Question Strength of Guidance for RAS Blockade in Patients With Stable CAD

January 19, 2017

News Daily News

Less Than Half of ACS Patients Are Prescribed High-Potency Statin Therapy

Michael O'Riordan

January 18, 2017

News Daily News

Interrupting Anticoagulation? New Guidance Aims to Simplify Periprocedural Decision-Making

January 09, 2017

News Daily News

Younger Adults With Severe Dyslipidemia Less Likely to Be Prescribed Statins

Michael O'Riordan

January 05, 2017

News Daily News

Best Anticoagulant in the TAVR Patient With A-fib? Small Study Makes Case for Apixaban

Michael O'Riordan

January 03, 2017

News Features

Coalition of the Willing: PERTs Aim to Disentangle ‘Gordian Knot’ of Acute Pulmonary Embolism

January 02, 2017

DAPT after Stenting: How Short When Needed and How Long When Tolerated?

Presentation Cardiovascular Interventions 2016

DAPT after Stenting: How Short When Needed and How Long When Tolerated?

Presenter: Dean J. Kereiakes

November 10, 2016

Optimal Duration of DAPT: Update on DAPT Guidelines

Presentation CCVVC 2016

Optimal Duration of DAPT: Update on DAPT Guidelines

Presenter: Roxana Mehran

June 16, 2016

News Daily News

Dabigatran an Alternative to Warfarin for Stroke Prevention in A-Fib Patients

September 03, 2009

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.